Long-term follow-up for adults with metabolic syndrome and prediabetes
Official title: Cohort Studies on Metabolic Syndrome and Prediabetes
Run by National Taiwan University Hospital · NCT07243821 · Data updated 2026-11-12
This project will follow adults with metabolic syndrome or prediabetes over time to see which lifestyle, metabolic, and nutritional factors predict progression to diabetes and related complications.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 2000 (estimated) |
| Sponsor | National Taiwan University Hospital Academic / other |
| Locations | 1 site (Taipei, Zhongzheng Dist) |
| Status | Recruiting |
| Started | October 31, 2025 |
| Main results expected | September 1, 2028 |
| Study ends | September 1, 2028 |
| Registry record updated | September 17, 2026 |
| Trial ID | NCT07243821 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older who meet the criteria for metabolic syndrome (three or more specified metabolic abnormalities) or have prediabetes (HbA1c 5.7–6.4%) and can give informed consent and complete physical assessments.
✕Probably not a fit
People without metabolic syndrome or prediabetes, those with advanced or unstable illness, or those unable to attend regular follow-up visits are unlikely to benefit directly from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational cohort will enroll adults diagnosed with metabolic syndrome or prediabetes at National Taiwan University Hospital and collect routine clinical, laboratory, nutritional, and physical function data at regular intervals. Researchers will build a database of metabolic profiles and biomarkers to track disease progression, incident diabetes, cardiovascular events, and nutrition-related functional decline. Longitudinal analyses will examine how lifestyle behaviors, body composition, and laboratory markers relate to outcomes and identify prognostic determinants. The cohort will support improved risk stratification and provide data to inform prevention strategies and future interventional studies.
Why it matters
Potential benefit: If successful, the project could help clinicians identify early warning signs and high-risk patients so interventions can be targeted to prevent diabetes and related complications.
How similar studies have gone: Similar cohort studies have previously identified lifestyle and metabolic predictors of diabetes and cardiovascular outcomes, but locally relevant longitudinal biomarker data remain limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria 1. Adults aged 18 years or older. 2. Individuals clinically diagnosed by a physician as having metabolic syndrome (meeting at least three of the following five criteria) or prediabetes: (A) Waist circumference: ≥ 90 cm in men or ≥ 80 cm in women, or body mass index (BMI) ≥ 27 kg/m². (B) Fasting plasma glucose (AC): ≥ 100 mg/dL. (C) Blood pressure: Systolic blood pressure ≥ 130 mmHg or diastolic blood pressure ≥ 85 mmHg. (D) Triglycerides (TG): ≥ 150 mg/dL. (E) High-density lipoprotein cholesterol (HDL-C): \< 40 mg/dL in men or \< 50 mg/dL in women. 3. Individuals meeting the definition of prediabetes, defined as glycated hemoglobin (HbA1c) between 5.7% and 6.4%. 4. Participants who are willing to participate in the study and have signed written informed consent. 5. Participants who are able to complete basic physical examinations and assessment procedures. Exclusion Criteria 1. Individuals unable to comprehend the study information or procedures. 2. Individuals unable to comply with the required assessments or study protocols. 3. Any other condition that, in the clinical judgment of the principal investigator, deems the individual unsuitable for participation.
Where it's running
-
National Taiwan University Hospital
Taipei, Zhongzheng Dist, Taiwan Recruiting
Study contacts
- Study coordinator: Chia-Wen Lu, Present Professor
- Email: biopsycosocial@gmail.com
- Phone: 886-2-23123456
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Heart, kidney, and metabolic health in Shanghai community residents
This follow-up will track people from the STONE cohort to see if changes in metabolic risk factors over time relate to heart and kidney outcomes.
-
Raising gut Akkermansia muciniphila with oral acetate (apple cider vinegar) during androgen deprivation therapy
This tests whether taking oral acetate (apple cider vinegar) can raise Akkermansia muciniphila levels in the gut and help metabolic and bone health in men starting androgen deprivation therapy for metastatic castration‑sensitive prostate cancer.
-
Observational cohort for non-alcoholic fatty liver disease and related conditions
This study is trying to learn more about non-alcoholic fatty liver disease and its related conditions by looking at patients with different stages of the disease and comparing them to people with diabetes and obesity who don't have it.
-
Registry for cardiometabolic risk factors
This study is testing how different heart and metabolic health factors affect people to help prevent future heart problems.
-
Fulvic acid supplements for metabolic syndrome
This study tests whether 50 mg or 100 mg of fulvic acid daily for 12 weeks can help people with metabolic syndrome or prediabetes.
-
Asprosin and miRNA Profiles in Young Women with Metabolic Syndrome
This study tests whether certain blood biomarkers, including asprosin and six microRNAs, differ between young women with metabolic syndrome and healthy peers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.